PATTERN OF CYTOKINES AND PHARMACOMODULATION IN SEPSIS-INDUCED BY CECAL LIGATION AND PUNCTURE COMPARED WITH THAT INDUCED BY ENDOTOXIN

被引:109
作者
VILLA, P
SARTOR, G
ANGELINI, M
SIRONI, M
CONNI, M
GNOCCHI, P
ISETTA, AM
GRAU, G
BUURMAN, W
VANTITS, LJH
GHEZZI, P
机构
[1] CNR,DEPT PHARMACOL,CTR CYTOPHARMACOL,I-20129 MILAN,ITALY
[2] PHARM FARMITALIA CARLO ERBA,DEPT IMMUNOL,MILAN,ITALY
[3] UNIV GENEVA,CTR MED,CH-1211 GENEVA,SWITZERLAND
[4] UNIV LIMBURG,FAC 2,DEPT SURG,6200 MD MAASTRICHT,NETHERLANDS
关键词
D O I
10.1128/CDLI.2.5.549-553.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The production of tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and IL-6 and their pharmacomodulation were evaluated in a model of polymicrobial sepsis induced in mice by cecal ligation and puncture (CLP) and were compared with the effects of endotoxin (lipopolysaccharide [LPS]) treatment. LPS levels rose as early as 1 h after CLP and increased further after 2 and 21 h. TNF-alpha was detectable in serum, spleen, liver, and lungs during the first 4 h, with a peak 2 h after CLP. IL-1 beta was measurable in serum after 24 h, and levels increased significantly in spleen and liver 4 and 8 h after CLP. IL-6 levels increased significantly in serum throughout the first 16 h after CLP. These cytokines were detectable after LPS injection, with kinetics similar to those after CLP but at a significantly higher level. To cast more light on the differences between these two animal models of septic shock, we studied the effects of different reference drugs. Pretreatment with dexamethasone (DEX); ibuprofen (IBU), an inhibitor of cyclooxygenase; and N-G-nitro-L-arginine, an inhibitor of nitric oxide synthase, significantly reduced survival, while chlorpromazine (CPZ) and TNF did not affect it. Only the antibiotics and pentoxifylline significantly increased survival in mice with CLP. However, CPZ and DEX protected the mice from LPS mortality. On inhibiting TNF-alpha with DEX, PZ, or pentoxifylline, survival was reduced, unchanged, and increased, respectively, and on increasing TNF-alpha with IBU and TNF, survival was decreased or unchanged, respectively, suggesting that the modulation of this cytokine does not play a significant role in sepsis induced by CLP, unlike treatment with LPS. The negative effects of IBU and N-G-nitro-L-arginine suggest a protective role by prostaglandins and nitric oxide in sepsis induced by CLP.
引用
收藏
页码:549 / 553
页数:5
相关论文
共 38 条
[1]   TREATMENT WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROTECTS RATS AGAINST THE LETHALITY, HYPOTENSION, AND HYPOTHERMIA OF GRAM-NEGATIVE SEPSIS [J].
ALEXANDER, HR ;
SHEPPARD, BC ;
JENSEN, JC ;
LANGSTEIN, HN ;
BURESH, CM ;
VENZON, D ;
WALKER, EC ;
FRAKER, DL ;
STOVROFF, MC ;
NORTON, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :34-39
[2]  
ALEXANDER HR, 1992, SURGERY, V112, P188
[3]  
BAKER CC, 1983, SURGERY, V94, P331
[4]  
BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554
[5]  
BERTINI R, 1993, EUR CYTOKINE NETW, V4, P39
[6]   PROTECTIVE EFFECT OF CHLORPROMAZINE AGAINST THE LETHALITY OF INTERLEUKIN-1 IN ADRENALECTOMIZED OR ACTINOMICIN-D-SENSITIZED MICE [J].
BERTINI, R ;
BIANCHI, M ;
MENGOZZI, M ;
GHEZZI, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :942-946
[7]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[8]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[9]  
CHALKIADAKIS GE, 1985, ARCH SURG-CHICAGO, V120, P1141
[10]   N(OMEGA)-AMINO-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHASE, RAISES VASCULAR-RESISTANCE BUT INCREASES MORTALITY-RATES IN AWAKE CANINES CHALLENGED WITH ENDOTOXIN [J].
COBB, JP ;
NATANSON, C ;
HOFFMAN, WD ;
LODATO, RF ;
BANKS, S ;
KOEV, CA ;
SOLOMON, MA ;
ELIN, RJ ;
HOSSEINI, JM ;
DANNER, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1175-1182